United Biomedical continues to contest hepatitis C virus (HCV) patent
This article was originally published in Clinica
United Biomedical (US) has informed Clinica that it is continuing to contest the validity of Chiron's UK and European hepatitis C patents. United Biomedical (UBI) produces the HCV tests which had been marketed by Organon Teknika in Europe until last year when the Hague District Court in the Netherlands and the UK High Court ordered injunctions against sales of HCV tests by Organon (and Murex) (see Clinica Nos 614, p 1 & 632, p 13). Earlier this month Organon decided not to pursue the dispute, but UBI is not giving up.
You may also be interested in...
Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.